Ocular measures for detection of driving impairment due to sleep loss, alcohol and benzodiazepine use

Not Applicable

Active, not recruiting

• Conditions: Effect of sleep restriction on driving performance; Effect of high therapeutic Temazepam dose on driving performance; Validation of ocular measures of drowsiness; Public Health - Other public health; Neurological - Studies of the normal brain and nervous system; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12610000263099
• Lead Sponsor: Institute for Breathing and Sleep

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

1) Current Australian driving licence, provisional or unrestricted;
2) Alcohol intake in standard drinks >0 average, <5/day for males and <3/day for females.

Exclusion Criteria

1) Epilepsy;
2) Diabetes requiring insulin;
3) Chronic psychiatric illness;
4) Visual impairment which does not correct with glasses;
5) Unable to speak and read English;
6) Drink more than 5 caffeinated beverages per day;
7) Significant daytime sleepiness (Epworth Sleepiness Scale score > 11);
8) Chronic neurological illness;
9) Chronic liver disease, diabetes requiring insulin or renal impairment;
10) Pregnancy or breast feeding;
11) Sleep apnoea, narcolepsy;
12) Use of sedating medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified